CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Learn where to invest small amounts of money to achieve the best results. Make informed decisions for your financial growth.
16,784 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A new IPO can spark excitement, but history shows many SPACs and tech IPOs struggle in the first year. This guide bre...
AI is rewriting investing playbooks. This piece uncovers a prophetic phrase from IBM and shows how it can inform smar...
In 2026, investors face a choice between a reliable components maker and a bold energy storage innovator. This guide ...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
As Buffett retires, Greg Abel takes the helm. Yet Berkshire’s quieter stock picker is delivering. This story breaks d...
SpaceX is the darling of space dreams and bold tech bets. This article breaks down what it would take for a public Sp...
When a mid-size firm makes a bold move into quantum tech, the market watches closely. This piece breaks down what Try...
Investors chase the next big tech story, and quantum computing stocks are no exception. This guide explains what tend...
A quick surge in a mining stock can spark headlines and questions. This guide breaks down the what, why, and how to r...
Age trends in retirement planning are reshaping how we save, invest, and withdraw. This guide breaks down what works ...
Geopolitical tensions in the Middle East have stirred oil markets and lifted energy stocks. Here’s how Occidental Pet...